PureTech Health plc
PRTC
$17.26
$0.120.70%
NASDAQ
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -90.86% | -90.86% | -97.90% | -97.90% | -55.20% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -90.86% | -90.86% | -97.90% | -97.90% | -55.20% |
| Cost of Revenue | -26.75% | -26.75% | -36.50% | -36.50% | -37.16% |
| Gross Profit | 22.71% | 22.71% | 27.60% | 27.60% | 35.53% |
| SG&A Expenses | 6.08% | 6.08% | -27.36% | -27.36% | 10.67% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -15.92% | -15.92% | -33.25% | -33.25% | -26.71% |
| Operating Income | 12.82% | 12.82% | 27.51% | 27.51% | 24.74% |
| Income Before Tax | -300.43% | -300.43% | 39.28% | 39.28% | 75.44% |
| Income Tax Expenses | -152.06% | -152.06% | 180.56% | 180.56% | 136.35% |
| Earnings from Continuing Operations | -91.33% | -91.33% | -202.22% | -202.22% | -8.85% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 1,202.38% | 1,202.38% | 104.57% | 104.57% | 111.21% |
| Net Income | -67.07% | -67.07% | -84.88% | -84.88% | 11.78% |
| EBIT | 12.82% | 12.82% | 27.51% | 27.51% | 24.74% |
| EBITDA | 11.65% | 11.65% | 27.88% | 28.43% | 24.56% |
| EPS Basic | -72.61% | -72.61% | -89.77% | -89.77% | 8.92% |
| Normalized Basic EPS | 40.28% | 40.28% | -135.89% | -135.89% | -41.37% |
| EPS Diluted | -72.22% | -72.22% | -88.47% | -88.47% | 10.00% |
| Normalized Diluted EPS | 40.28% | 40.28% | -135.89% | -135.89% | -41.37% |
| Average Basic Shares Outstanding | -3.09% | -3.09% | -2.63% | -2.63% | -3.30% |
| Average Diluted Shares Outstanding | -3.09% | -3.09% | -2.63% | -2.63% | -3.30% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |